Flow cytometric characteristics of alveolar lymphocytes (AL) obtained from the control group - Proposal of normal value range of AL subsets in nonsmokers

Central-European Journal of Immunology

Volumn 29, Issue 3-4, 2004, Pages 63-72

  Kopiński, Piotr ^a,c   Szczeklik, Jerzy ^a   Lackowska, Bozena ^b   Soja, Jerzy ^a   Szlubowski, Artur ^a   Nalepa, Piotr ^d   Jedynak, Urszula ^a   Sładek, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Alveolar lymphocytes; Bronchoalveolar lavage; Flow cytometry; Lymphocyte subsets; Mean fluorescence intensity

Indexed keywords

ANTIBODY; CD3 ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS CELL; LUNG LAVAGE; MALE; PERIPHERAL LYMPHOCYTE; SMOKING;

EID: 33644597464     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fireman E, Vardinon N, Burke M, et al. (1998): Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. Eur Respir J 11: 706-711.
2. Haslam PL, Baughman RP (1999): Report of ERS Task Force: guidelines for measurements of acellular components and standardization of BAL. Eur Respir J 14: 245-248.
3. LW, Rossi GA, Bjermer L, et al. (1992): The value of bronchoalveolar lavage in the diagnosis and prognosis of sarcoidosis. Eur Respir Rev 2 (8): 75-82.
4. Saltini C, Amicosante M, Franchi A, et al. (1998): Immunogenetic basis on environmental lung disease: Lessons from the berilliosis model. Eur Respir J 12: 1463-1475.
5. Semenzato G, Bjermer L, Costabel U, et al. (1992): Clinical role of bronchoalveolar lavage in extrinsic allergic alveolitis. Eur Respir Rev 2: 69-74.
6. Chłap Z, Czarnobilska E, Kopinski P, et al. (2000): Cytoimmunological atlas of bronchoalveolar lavage (BAL). Ed. Medycyna Praktyczna, Kraków.
7. Agostini C, Zambello R, Sancetta A, et al. (1996): Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 153: 1359-1367.
8. Marathias K, Pinto C, Rodberg G, et al. (1994): The T cell antigen receptor CD3:CD4 molecular complex is diminished on the surface of pulmonary lymphocytes. Am J Pathol 145: 1219-1227.
9. Stridh H, Planck A, Gigliotti D, et al. (2002): Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis. Thorax 57 (10): 897-901.
10. Szczeklik J, Trojan J, Kopiński P, et al. (2004): Apoptosis in bronchoalveolar lavage lymphocytes (L-BAL) in pneumoconioses. Przeg Lek 61 (4): 235-240.
11. Dauber JH, Wagner M, Brunsvold S, et al. (1992): Flow cytometric analysis of lymphocyte phenotypes in bronchoalveolar lavage fluid: Comparison of a two-color technique with a standard immunoperoxidase assay. Am J Respir Cell Mol Biol 7: 531-41.
12. Kopiński P (1997): Flow cytometry applied in cytological changes assessment in interstitial lung diseases. Fol Med Cracov XXXVIII (3-4): 69-115.
13. Parker DJ, Haslam PL (1988): A new method to improve the discrimination between lymphocytes and contaminating erythrocytes in flow cytometric analytical techniques. J Immunol Methods; 110: 37-45.
14. Popp W (1995): Die Bronchoalveolaere Lavage, 8 Rebegensburger Kurs. W: Schrift "Anwedungen der Durchfluorozytometrie in der Klinischen Zelldiagnostik". Universitaet Regensburg, Klinikum. Ratyzbona; 1-9.
15. Merchant RK, Schwartz DA, Helmers RA, et al. (1992): Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis 146: 448-453.
16. BAL Cooperative Steering Comittee (1990): Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. 6. Lymphocyte surface antigen phenotypes in broncholaveolar lavage fluid and peripheral blood. Am Rev Respir Dis 141 (5): S169-S202.
17. Becker S, Harris DT, Koren HS (1990): Characterization of normal human lung lymphocytes and interleukin-2-induced lung T cell lines. Am J Respir Cell Mol Biol 3: 441-448.
18. Harbeck RJ (1998): Immunophenotyping of bronchoalveolar lavage lymphocytes. Minireviews. Clin Diagn Lab Immunol 5 (3): 271-277.
19. Ancochea J, Gonzalez A, Sanchez MJ, et al. (1993): Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. Chest; 104 (1): 32-37.
20. Costabel U: Atlas of bronchoalveolar lavage. Chapman & Holl, London, 1998.
21. Hoser G, Kawiak J, Domagala-Kulawik J, et al. (1999): Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Fol Hist Cytobiol 37 (1): 25-30.
22. Pirozynski M, Pirozynska E (1999): Płukanie oskrzelowo- pȩcherzykowe. In: Pirozyński M: Bronchofiberoskopia. á-medica press, Bielsko-Biała, 1999, 118-127.
23. Reynolds HY, Huck J (1990): Immunologic responses in the lung. Respiration 57: 221-228.
24. Saltini C, Kirby M, Trapnell C, Tamura N, Crystal RG (1990): Biased accumulation of T lymphocytes with "memory" - type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 171: 1123-1140.
25. Agostini C, Chilosi M, Zambello R, et al. (1993): Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J 6 (9): 1378-1401.
26. Curtis JL, Kim S, Scott PJ, Buechner-Maxwell VA (1995): Adhesion receptor phenotypes of murine lung CD4+ T cells during the pulmonary immune response to sheep erythrocytes. Am J Respir Cell Mol Biol 12 (5): 520-530.
27. Herry I, Bonay M, Bouchonnet F, et al. (1996): Extensive apoptosis of lung T-lymphocytes maintained in vitro. Am J Respir Cell Mol Biol 15: 339-347.
28. Pabst R, Binns RM (1996): Lymphocytes migrate from the bronchoalveolar lavage space to regional bronchial lymph nodes. Am J Respir Crit Care Med 151: 495-499.
29. Klech H, Pohl W (1989): Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Resp J 2: 561-585.
30. Chlap Z, Jedynak U, Sladek K (1998): Mast cell: diagnostic importance in cytology of bronchoalveolar lavage fluid in bronchial asthma and interstitial lung diseases. Pneumonol Alergol Pol 66, 5-6: 321-329.
31. Representive references ranges for Simultest IMK Plus parameters in hematologically normal adults as percentages of total lymphocytes (1992). In: Simultest TM IMK Plus, instruction, BD Immunocytometry Systems. San Jose.
32. Satake N, Nagai S, Kawatani A, et al. (1993): Density of phenotypic markers on BAL T-lymphocytes in hypersensitivity pneumonias, pulmonary sarcoidosis and bronchiolitis obliterans with organizing pneumonia. Eur Respir J 6: 477-482.
33. Yamada M, Tamura N, Shirai T, Kira S (1986): Flow cytometric analysis of lymphocyte subsets in the bronchoalveolar lavage fluid and peripheral blood of healthy volunteers. Scan J Immunol 24: 559-569.
34. Raju B, Tung CF, Cheng D, et al. (2001): In situ activation of helper T cells in the lung. Infect Immun 69(8): 4790-98.
35. Reynolds HY (2000): Advances in understanding pulmonary host defense mechanisms: dendritic cell function and immunomodulation. Curr Opin Pulm Med 6: 209-216.
36. Costabel U, Guzman J (1992): Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J 5: 776-779.